BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11123895)

  • 1. Substrate competitive inhibitors of IGF-1 receptor kinase.
    Blum G; Gazit A; Levitzki A
    Biochemistry; 2000 Dec; 39(51):15705-12. PubMed ID: 11123895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics.
    Blum G; Gazit A; Levitzki A
    J Biol Chem; 2003 Oct; 278(42):40442-54. PubMed ID: 12869569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.
    Mehdi MZ; Vardatsikos G; Pandey SK; Srivastava AK
    Biochemistry; 2006 Sep; 45(38):11605-15. PubMed ID: 16981720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.
    Girnita A; Girnita L; del Prete F; Bartolazzi A; Larsson O; Axelson M
    Cancer Res; 2004 Jan; 64(1):236-42. PubMed ID: 14729630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents.
    Steiner L; Blum G; Friedmann Y; Levitzki A
    Eur J Pharmacol; 2007 May; 562(1-2):1-11. PubMed ID: 17376430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal chemistry approaches to target the kinase activity of IGF-1R.
    Garcia-Echeverria C
    IDrugs; 2006 Jun; 9(6):415-9. PubMed ID: 16752311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment.
    van der Meel R; Oliveira S; Altintas I; Haselberg R; van der Veeken J; Roovers RC; van Bergen en Henegouwen PM; Storm G; Hennink WE; Schiffelers RM; Kok RJ
    J Control Release; 2012 Apr; 159(2):281-9. PubMed ID: 22227023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells.
    Zovko A; Novak M; Hååg P; Kovalerchick D; Holmlund T; Färnegårdh K; Ilan M; Carmeli S; Lewensohn R; Viktorsson K
    Oncotarget; 2016 Aug; 7(31):50258-50276. PubMed ID: 27384680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells.
    Wen B; Deutsch E; Marangoni E; Frascona V; Maggiorella L; Abdulkarim B; Chavaudra N; Bourhis J
    Br J Cancer; 2001 Dec; 85(12):2017-21. PubMed ID: 11747348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor.
    Wood ER; Shewchuk L; Hassel A; Nichols J; Truesdale AT; Smith D; Carter HL; Weaver K; Barrett G; Leesnitzer T; Alvarez E; Bardera AI; Alamillo A; Cantizani J; Martin J; Smith GK; Jensen DE; Xie H; Mook R; Kumar R; Kuntz K
    Biochem Pharmacol; 2009 Dec; 78(12):1438-47. PubMed ID: 19665448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: advantages in comparison with competitive inhibitors.
    Lesuisse D; Mauger J; Nemecek C; Maignan S; Boiziau J; Harlow G; Hittinger A; Ruf S; Strobel H; Nair A; Ritter K; Malleron JL; Dagallier A; El-Ahmad Y; Guilloteau JP; Guizani H; Bouchard H; Venot C
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2224-8. PubMed ID: 21441024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.
    Azar ZM; Mehdi MZ; Srivastava AK
    Can J Physiol Pharmacol; 2006 Jul; 84(7):777-86. PubMed ID: 16998541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule ATP-competitive dual IGF-1R and insulin receptor inhibitors: structural insights, chemical diversity and molecular evolution.
    Jin M; Wang J; Buck E; Mulvihill MJ
    Future Med Chem; 2012 Mar; 4(3):315-28. PubMed ID: 22393939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
    Bouallegue A; Vardatsikos G; Srivastava AK
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ), a lipid signalling enigma.
    Giudici ML; Clarke JH; Irvine RF
    Adv Biol Regul; 2016 May; 61():47-50. PubMed ID: 26710750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for small molecule inhibitors of insulin-like growth factor receptor (IGF-1R) kinase: comparison of homogeneous time-resolved fluorescence and 33P-ATP plate assay formats.
    Wang Y; Malkowski M; Hailey J; Turek-Etienne T; Tripodi T; Pachter JA
    J Exp Ther Oncol; 2004 Jul; 4(2):111-9. PubMed ID: 15500006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
    Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A
    Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296.
    Kovalenko M; Rönnstrand L; Heldin CH; Loubtchenkov M; Gazit A; Levitzki A; Böhmer FD
    Biochemistry; 1997 May; 36(21):6260-9. PubMed ID: 9174341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of Annexin II via activation of insulin receptor and insulin-like growth factor receptor.
    Zhao WQ; Chen GH; Chen H; Pascale A; Ravindranath L; Quon MJ; Alkon DL
    J Biol Chem; 2003 Feb; 278(6):4205-15. PubMed ID: 12431980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.
    Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G
    Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.